IL17A and colitis: Consistently, we found that the recipient mice transferred with Foxp1-deficient iTreg cells developed more severe colitis, indicated by the greater body weight loss (Fig 5C) and more IFNγ- or IL-17A–producing T cells in the colons (Fig 5D).